Mishra shree kumar

• Senior Consultant Pulmonologist, AIIMS Bhubaneswar (2015–Present)
  • Specializing in respiratory diseases, COPD, and asthma management.
  • Leading a team for advanced pulmonary research and patient care.
  • Conducting workshops on lung health and post-COVID respiratory care.
• Associate Professor of Pulmonology, SCB Medical College, Cuttack (2010–2015)
  • Teaching and training postgraduate medical students in pulmonology.
  • Conducting research on respiratory infections and treatment innovations.
• Resident Pulmonologist, AIIMS Delhi (2003–2010)
  • Gained expertise in treating chronic lung diseases and ICU respiratory care.
  • Assisted in over 2,500 cases related to lung disease and ventilation therapy.

• Lead researcher in a study on "The Impact of Air Pollution on Respiratory Health in India" (Published in the Indian Journal of Pulmonology, 2018).
• Co-authored a research paper on "COVID-19 and Post-Infection Pulmonary Complications" (Presented at the National Pulmonology Conference, 2021).
• Participated in a WHO-funded study on "Tuberculosis and Multi-Drug Resistance in Eastern India".

• Best Pulmonologist Award – Indian Chest Society (2019).
• Excellence in Critical Care and Ventilation Management – Indian Medical Association (2020).
• Lifetime Contribution to Respiratory Medicine – Ministry of Health, Government of India (2022).

Dr. Shree Kumar Mishra has made significant contributions to pulmonology, respiratory diseases, and critical care research, with multiple published studies in prestigious medical journals. His study, "The Impact of Air Pollution on Respiratory Health in India", published in the Indian Journal of Pulmonology (2018), analyzed the rising cases of lung disease due to increasing pollution and proposed preventive strategies. Additionally, he co-authored "COVID-19 and Post-Infection Pulmonary Complications", presented at the National Pulmonology Conference (2021), which focused on long-term lung complications post-COVID-19 and rehabilitation strategies. Furthermore, he played a crucial role in a WHO-funded study on Tuberculosis and Multi-Drug Resistance in Eastern India, shedding light on the increasing resistance to first-line TB treatments and advocating for innovative treatment approaches. His research and clinical expertise have significantly improved the management of lung diseases and critical care treatment protocols in India.